Page 2 – NCAL Research Spotlight

Migraine genetics study finds intriguing connections with other medical conditions

July 22, 2021
Genetics, Neurological, Press Release, Uncategorized
0 Comments

A Kaiser Permanente genetic analysis found 82 locations on the human genome associated with migraine, 48 of them newly identified, including 3 specific to women, who experience migraine much more frequently than men.

Risk of blood clots more than 3-fold higher in hospitalized adults with COVID-19

Kaiser Permanente study found Black patients as well as patients who had obesity, liver disease, or sepsis or other signs of infection were among those more likely to be at high risk for a blood clot.

‘COVID toes’ were likely not caused by COVID-19, in most cases

Kaiser Permanente study suggests the increased incidence of chilblains — or, COVID toes — seen during pandemic was related to behavior changes, not the coronavirus.

Kaiser Permanente researchers and physicians take part in leading clinical oncology conference

Research presented at the American Society for Clinical Oncology annual meeting amplified the ways the Division of Research and The Permanente Medical Group advance cancer care.

Uncommon kidney disorder significantly increases risk of heart disease and end-stage kidney disease

June 18, 2021
Cardiovascular, Cardiovascular Disease, Kidney disease
0 Comments

Kaiser Permanente study findings highlight the need for patients with primary nephrotic syndrome to be identified as early as possible to prevent complications.

Study identifies genetic clues for increased risk of age-related cataract

June 14, 2021
Eye, Genetics, Ophthalmology, Press Release, Uncategorized
0 Comments

Using data from Kaiser Permanente and United Kingdom biobanks, researchers have identified new locations on the human genome that could relate to the risk of age-related cataract.

COVID-19 vaccine trial enrolls children aged 5-11 at 3 sites in Northern California

June 9, 2021
Clinical trials, COVID19, Infectious disease, Uncategorized, Vaccines
2 Comments

About 75 children are scheduled to receive their first vaccination against COVID-19 as part of the Pfizer/BioNTech vaccine clinical trial through Kaiser Permanente Northern California.

Study finds no link between autism and common antidepressant when used in pregnancy

June 8, 2021
Autism, Maternal/infant health, Mental health, Perinatal health, Women’s health
0 Comments

Mothers with psychiatric conditions such as depression and anxiety were more likely to have a child with autism than mothers without such conditions, new research led by Kaiser Permanente investigators finds. But the analysis found no association between use of common antidepressants by pregnant women and likelihood of autism in their children.

Continuous glucose monitors help patients manage type 2 diabetes

June 2, 2021
Delivery Science, Diabetes, Endocrinology, Health maintenance, Uncategorized
0 Comments

New Kaiser Permanente study finds continuous glucose monitors are associated with improved blood sugar control and fewer visits to the emergency room for hypoglycemia in type 2 diabetes patients treated with insulin.

Emergency care for heart attacks and strokes rebounds

June 2, 2021
Cardiovascular, Cardiovascular Disease, COVID19, Emergency department, Neurological, Press Release, Stroke
0 Comments

Kaiser Permanente study finds declines in heart attack hospitalizations and emergency care for possible strokes reported during onset of the COVID-19 pandemic not seen in subsequent surges.